<DOC>
	<DOCNO>NCT00929175</DOCNO>
	<brief_summary>Obstructive sleep apnea syndrome ( OSAS ) link resistant hypertension , effect treatment OSAS resistant hypertension establish . In double-blind randomized clinical trial patient resistant hypertension least moderate sleep apnea randomize receive therapeutic CPAP Placebo CPAP eight week ambulatory set . The investigator want determine difference hypertension control 2 management strategy .</brief_summary>
	<brief_title>Antihypertensive Effect Continuous Positive Airway Pressure Resistant Hypertensive Patients With Sleep Apnea</brief_title>
	<detailed_description>This double blind , randomize , placebo control trial . Participants consecutive patient resistant hypertension , define uncontrolled BP , despite concurrent use 3 antihypertensive agent , include diuretic , adherence treatment without white coat phenomenon . All participant diagnosis least moderate OSAS , define AHI &gt; 15 portable monitoring sleep exam . Participants assign active CPAP sham-CPAP . The main outcome change 24-hour ambulatory blood pressure ( ABP ) monitoring value baseline two month active CPAP sham CPAP</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Clinical diagnosis resistant hypertension Apnea/hypopnea index &gt; 15 Cardiac surgery last 3 month Serious arrhythmias Insulin dependent diabetes Debilitating neurological disease severe COPD</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Resistant Hypertension</keyword>
	<keyword>Sleep apnea syndrome</keyword>
	<keyword>Treatment</keyword>
</DOC>